Trending...
- BEVERAGE INDUSTRY PIONEER MICHAEL MICHAIL LAUNCHING XPRESS HARDER ICED TEA - 125
- Skool O' Foolz Drops Rapperz Delite on Gum Drop Hip Hop You Tube Channel From TVS Records - 114
- Alexandria Bedolla: An Award-Winning Baker with a Passion for Sweets
LOS ANGELES - Californer -- A team of researchers from the University of California, Los Angeles, Texas A&M University, and Florida International University have unveiled a groundbreaking innovation in diabetes management with the development of a novel continuous glucose monitoring (CGM) system. The new system integrates an insertable glucose biosensor with a phosphorescence lifetime imager (PLI) and advanced machine learning algorithms to offer a more reliable and cost-effective solution for real-time glucose monitoring.
Diabetes, a chronic condition affecting over 450 million individuals globally, necessitates continuous and precise glucose monitoring to avoid severe health complications. Traditional glucose monitoring methods often require frequent finger pricking, leading to discomfort and reduced adherence to glucose management regimens. While existing CGM systems have alleviated some of these challenges, they are still associated with high costs, limited sensor lifetimes, and potential tissue irritation due to the invasive nature of electrode insertion.
More on The Californer
The new CGM system addresses these limitations by utilizing a biocompatible phosphorescence-based biosensor that is implanted subcutaneously. Unlike conventional CGMs that rely on electrochemical reactions, this innovative system detects glucose levels through the modulation of phosphorescence signals emitted by the sensor. The emitted signal, which has a significantly longer lifetime compared to tissue autofluorescence, is captured by the compact PLI through the skin, allowing for a non-invasive readout of glucose levels.
One of the most significant advancements of this system is its ability to accurately monitor glucose levels even in the presence of sensor misalignment, a common issue in wearable devices. The PLI is equipped with a neural network-based model that processes phosphorescence lifetime images to not only infer glucose levels but also detect misalignments, prompting the user to correct the device's position if necessary. This feature ensures that the glucose readings remain accurate and reliable, even during physical activity or movement, which can often cause misalignments.
More on The Californer
In vitro testing demonstrated that the PLI achieved an accuracy of 88.8% in classifying glucose concentrations across normal, low, and high ranges, with an additional capability of identifying misalignments with 100% accuracy. This robust performance suggests that the system can significantly improve the quality of glucose monitoring, potentially reducing the need for frequent recalibration and offering a more seamless experience for users.
The insertable biosensor is smaller and more durable than current alternatives, with a stable phosphorescence response lasting up to 12 weeks and enzyme activity maintained for over four weeks. This extended lifespan reduces the need for frequent sensor replacements, which is a major contributor to the high cost of existing CGM systems. This new CGM is cost effective and PLI's compact and portable design, coupled with its affordability, makes it an attractive option for widespread adoption.
Researchers envision broader applications for the PLI system for multiplexed sensing, where multiple biomarkers can be monitored simultaneously.
Original paper: https://pubs.acs.org/doi/10.1021/acsnano.4c06527
Diabetes, a chronic condition affecting over 450 million individuals globally, necessitates continuous and precise glucose monitoring to avoid severe health complications. Traditional glucose monitoring methods often require frequent finger pricking, leading to discomfort and reduced adherence to glucose management regimens. While existing CGM systems have alleviated some of these challenges, they are still associated with high costs, limited sensor lifetimes, and potential tissue irritation due to the invasive nature of electrode insertion.
More on The Californer
- Congressional Leaders Join Press Announcement for "I Am An American" Traveling Exhibit About World War II Nisei Soldiers USA - English
- California: TOMORROW: Governor Newsom to take action on housing & homelessness with new legislation and funding announcements
- California: Delta's largest-ever tidal wetland restoration project completed, reducing flood risk and supporting wildlife
- Cryobank America Expands to Orange County To Recruit The Nation's Most Elite Sperm Donors
- California: Governor Newsom's housing and homeless accountability unit unlocks 7,500+ new housing units
The new CGM system addresses these limitations by utilizing a biocompatible phosphorescence-based biosensor that is implanted subcutaneously. Unlike conventional CGMs that rely on electrochemical reactions, this innovative system detects glucose levels through the modulation of phosphorescence signals emitted by the sensor. The emitted signal, which has a significantly longer lifetime compared to tissue autofluorescence, is captured by the compact PLI through the skin, allowing for a non-invasive readout of glucose levels.
One of the most significant advancements of this system is its ability to accurately monitor glucose levels even in the presence of sensor misalignment, a common issue in wearable devices. The PLI is equipped with a neural network-based model that processes phosphorescence lifetime images to not only infer glucose levels but also detect misalignments, prompting the user to correct the device's position if necessary. This feature ensures that the glucose readings remain accurate and reliable, even during physical activity or movement, which can often cause misalignments.
More on The Californer
- Alair Homes Expands in California with the Launch of Alair Tri Counties
- Star Trek Section 31 Bluetooth ComBadge Released!
- Halloween Fun At Simi Valley YMCA's Fall Festival & Trunk-Or-Treat - October 19
- Latest Disability Rate After Age 65 Shared By Long-Term Care Insurance Association
- California: Debunking Big Oil's lies ahead of first special session hearings
In vitro testing demonstrated that the PLI achieved an accuracy of 88.8% in classifying glucose concentrations across normal, low, and high ranges, with an additional capability of identifying misalignments with 100% accuracy. This robust performance suggests that the system can significantly improve the quality of glucose monitoring, potentially reducing the need for frequent recalibration and offering a more seamless experience for users.
The insertable biosensor is smaller and more durable than current alternatives, with a stable phosphorescence response lasting up to 12 weeks and enzyme activity maintained for over four weeks. This extended lifespan reduces the need for frequent sensor replacements, which is a major contributor to the high cost of existing CGM systems. This new CGM is cost effective and PLI's compact and portable design, coupled with its affordability, makes it an attractive option for widespread adoption.
Researchers envision broader applications for the PLI system for multiplexed sensing, where multiple biomarkers can be monitored simultaneously.
Original paper: https://pubs.acs.org/doi/10.1021/acsnano.4c06527
Source: ucla ita
Filed Under: Health
0 Comments
Latest on The Californer
- Pasolivo Olive Oil Celebrates Historic Achievement as Most Awarded U.S. Producer at NYIOOC
- Diana Partners With OpsVeda To Leverage AI-ML To Get Closer To Its Consumers
- California: Governor Newsom signs bills to protect digital likeness of performers
- SMAart Studio Announces Fall Pottery Classes
- Gold and Fractal EMS Announce a Partnership for an American BMS USA - English USA - English
- California: TODAY: Governor Newsom Fireside Chat with Salesforce Chair & CEO Marc Benioff
- California: Governor Newsom provides two-month update on CHP's East Bay surge operation
- California: Governor Newsom proclaims Constitution Day and Citizenship Day
- Vantiva Receives 2024 RDK "Distinguished Leader Award"
- California: Governor Newsom proclaims Strong Start & Beyond Day as state launches new maternal health initiative
- BK Adventure Announces the 2024 Haunted Bioluminescence Tour
- 26 Hidden Costs of Home Ownership
- California: Governor Newsom proclaims Latino Heritage Month 2024
- Skillz Inc. (NYSE: SKLZ) Lawsuit Update: Investors who purchased Flying Eagle Acquisition Corp. (formerly NYSE: FEAC) shares should contact the Shareholders Foundation
- Dreamforce 2024 to Mark the Release of ShellBlack's Latest Cost-Effective Accelerator for Salesforce Financial Services Cloud
- AVTECH Announces New Room Alert Bundles for Heat Safety and Enhanced Indoor Air Quality Monitoring
- VerifyNow Launches Groundbreaking FICA Compliance Platform for South African Businesses
- Introducing MyTennisTrip.com: Your Ultimate Tennis Travel Companion
- Orbano, Your Trusted Sign Supplier With a Large Inventory of Top-Quality Sign Materials, Equipment and More
- Award-Winning Writer Thrills Mystery Lovers with The Button Collector on September 17